What is G LNK?
G LNK operates as a sophisticated healthcare data platform, meticulously engineered to elevate sales and marketing initiatives within the life sciences industry. By furnishing granular insights into healthcare professionals (HCPs) and healthcare institutions, G LNK empowers organizations with actionable intelligence. The platform boasts access to an extensive database of over 9.2 million HCP profiles and data points for more than 68,000 hospitals and health systems. This comprehensive data repository enables G LNK to offer advanced tools for intelligent search, in-depth analytics, and targeted outreach. Key functionalities include real-time payment tracking, detailed medical device utilization data, and precise prescribing and treatment analytics, all designed to optimize engagement with clinicians and key decision-makers in the life sciences sector.
How much funding has G LNK raised?
G LNK has raised a total of $500K across 1 funding round:
Angel/Pre-Seed
$500K
Angel/Pre-Seed (2025): $500K with participation from Y Combinator
Key Investors in G LNK
Y Combinator
Y Combinator is a renowned startup accelerator known for backing early-stage companies across various technology sectors, providing seed funding and mentorship to help them scale.
What's next for G LNK?
The recent major strategic investment into G LNK signals a strong validation of its market position and future growth potential. This capital infusion is expected to fuel further expansion of its data capabilities and technological infrastructure, enabling G LNK to deepen its penetration within the life sciences market. The company is poised to enhance its offerings, potentially exploring new analytical tools or expanding its data coverage to address emerging trends in healthcare. This strategic financing will likely support G LNK's mission to become an indispensable partner for life sciences organizations seeking to navigate the complexities of HCP engagement and market dynamics.
See full G LNK company page
